WASHINGTON – Every edition of Transcatheter Cardiovascular Therapeutics has at least one big announcement, but the star of this year's TCT is without a doubt the PARTNER (Placement of AoRTic TraNscathetER Valve Trial) study conducted by Edwards Lifesciences (Irvine, California) for the Sapien aortic valve for transcatheter delivery. The announcement of the outcomes for this study drew a standing-room only crowd at the cavernous main arena at the apex of the Washington Convention Center, but two flies appeared in the ointment. (Medical Device Daily) Read More
